Albrechtsen, Hanne, and Elin K. Jacob. 1998.

The Dynamics of Classification

Systems as Boundary Objects for Cooperation in the Electronic Library.
Library Trends 47, no. 2: 293-312.

Anderson, M J. 1993. Collaborative integration in the Canadian

pharmaceutical industry. Environment and Planning A 25, no. 12: 1815 –
1838. doi:10.1068/a251815.

Anon. The Diffusion of Information Technology among Health Maintenance

Organizations 25. http://journals.lww.com/hcmrjournal/Fulltext/2000/04000/
The_Diffusion_of_Information_Technology_among.3.aspx.

Berndt, Ernst R. 2001. The U.S. Pharmaceutical Industry: Why Major Growth
In Times Of Cost Containment? Health Aff 20, no. 2 (March 1): 100-114. doi:
10.1377/hlthaff.20.2.100.

Bharadwaj, Anandhi S., Sundar G. Bharadwaj, and Benn R. Konsynski. 1999.

Information Technology Effects on Firm Performance as Measured by Tobin's
q. Management Science 45, no. 7 (July): 1008-1024.

Birnbaum H.G.[1], Cremieux P.Y.[1], Greenberg P.E.[1], LeLorier J.[2],

Ostrander J.[1], and Venditti L.[1]. 1999. Using Healthcare Claims Data for
Outcomes Research and Pharmacoeconomic Analyses. PharmacoEconomics 16
(July): 1-8.

Boudreau, Marie-Claude, Karen D. Loch, Daniel Robey, and Detmar Straud.

1998. Going Global: Using Information Technology to Advance the
Competitiveness of the Virtual Transnational Organization. The Academy of
Management Executive (1993) 12, no. 4 (November): 120-128.

Carl Sherman. 2001. Lithium Decline Reflects Economic, Not Clinical Trends:
Since 1965, 24 studies have reported a drop in bipolar recurrence with
lithium 29, no. 12 (December 1): 1.

Carter, Franklin J., Thani Jambulingam, Vipul K. Gupta, and Nancy Melone.
2001. Technological innovations: a framework for communicating diffusion
effects. Information & Management 38, no. 5 (April): 277-287. doi:10.1016/
S0378-7206(00)00065-3.

Chen, Yu-Shan, and Ke-Chiun Chang. 2009. Using neural network to analyze
the influence of the patent performance upon the market value of the US
pharmaceutical companies. Scientometrics 80, no. 3 (4): 637-655. doi:
10.1007/s11192-009-2095-2.

Chilvers, Jason, and James Evans. 2009. Understanding networks at the

science-policy interface. Geoforum 40, no. 3 (May): 355-362. doi:10.1016/
j.geoforum.2009.03.007.

Clarke, Adele, and Virginia L. Olesen. 1999. Revisioning women, health and
healing. Routledge.

DESHPANDE, APARNA [1], AJIT [1] MENON, MATTHEW [1] PERRI III, and GEORGE
[2] ZINKHAN. 2004. Direct-to-Consumer Advertising and its Utility in Health
Care Decision Making: A Consumer Perspective. Journal of Health
Communication 9 (December): 499-513. doi:10.1080/10810730490523197.

Dormann, H., A. Neubert, M. Criegee-Rieck, T. Egger, M. Radespiel-Tröger,

T. Azaz-Livshits, M. Levy, K. Brune, and E.G. Hahn. 2004. Readmissions and
adverse drug reactions in internal medicine: the economic impact. Journal
of Internal Medicine 255, no. 6: 653-663. doi:10.1111/j.
1365-2796.2004.01326.x.

Fairman, Kathleen A, and Frederic R Curtiss. 2007. The elephant in the

pharmacy: patient choice is the big challenge that no one talks about in
affordability of prescription drugs. Journal of Managed Care Pharmacy: JMCP
13, no. 7 (September): 620-622.

Fountoulakis, Konstantinos N., Eduard Vieta, Constantin Bouras, Grigorios

Notaridis, Panteleimon Giannakopoulos, George Kaprinis, and Hagop Akiskal.
2007. A systematic review of existing data on long-term lithium therapy:
neuroprotective or neurotoxic? The International Journal of
Neuropsychopharmacology 11, no. 02 (5). doi:10.1017/S1461145707007821.
http://www.journals.cambridge.org/abstract_S1461145707007821.

GORMAN, M. E. 2004. Collaborating on convergent technologies. Ann. NY Acad.

Sci 1013: 1–13.

Haraway, Donna. 1988. Situated Knowledges: The Science Question in Feminism

and the Privilege of Partial Perspective. Feminist Studies 14, no. 3
(Autumn): 575-599.

Henegar, Corneliu, Cédric Bousquet, Agnès Lillo-Le Louët, Patrice Degoulet,

and Marie-Christine Jaulent. Building an ontology of adverse drug reactions
for automated signal generation in pharmacovigilance. Computers in Biology
and Medicine 36, no. 7-8 (July): 748-767. doi:10.1016/j.compbiomed.
2005.04.009.

Herasevich, Vitaly, Mark T. Keegan, David Tines, Michael M. Malinchoc,

Andrew C. Hanson, Puneet Katyal, Rolf D. Hubmayr, Bekele Afessa, and Ognjen
Gajic. 2007. "ICU of the future": informatics infrastructure for syndrome
surveillance, decision support, data mining, and modeling of critical
illness. Journal of Critical Care 22, no. 4 (December): 340. doi:10.1016/
j.jcrc.2007.10.016.

Hickman, C. 2009. Cheerful prospects and tranquil restoration: the visual

experience of landscape as part of the therapeutic regime of the British
asylum, 1800--60. History of Psychiatry 20, no. 4 (11): 425-441. doi:
10.1177/0957154X08338335.

Jaakkola, Elina, and Maija Renko. 2007. Critical innovation characteristics

influencing the acceptability of a new pharmaceutical product format.
Journal of Marketing Management 23 (April): 327-346. doi:
10.1362/026725707X196404.

Jennings, Pamela. 2005. Tangible social interfaces: critical theory,

boundary objects and interdisciplinary design methods. In Proceedings of
the 5th conference on Creativity \& cognition, 176-186. London, United
Kingdom: ACM. doi:10.1145/1056224.1056249. http://portal.acm.org/
citation.cfm?id=1056249.

Jones, Judith K. 2001. The role of data mining technology in the

identification of signals of possible adverse drug reactions: value and
limitations. Current Therapeutic Research 62, no. 9 (September): 664-672.
doi:10.1016/S0011-393X(01)80072-2.

Jones, Peter B., Thomas R. E. Barnes, Linda Davies, Graham Dunn, Helen
Lloyd, Karen P. Hayhurst, Robin M. Murray, Alison Markwick, and Shon W.
Lewis. 2006. Randomized Controlled Trial of the Effect on Quality of Life
of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost
Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS
1). Arch Gen Psychiatry 63, no. 10 (October 1): 1079-1087. doi:10.1001/
archpsyc.63.10.1079.

Kraut, Robert, Charles Steinfield, Alice P. Chan, Brian Butler, and Anne
Hoag. 1999. Coordination and Virtualization: The Role of Electronic
Networks and Personal Relationships. Organization Science 10, no. 6
(December): 722-740.

Lankinen, Kari S., Tero Levola, Kati Marttinen, Inka Puumalainen, and Arja
Helin-Salmivaara. 2004. Industry guidelines, laws and regulations ignored:
quality of drug advertising in medical journals. Pharmacoepidemiology and
Drug Safety 13, no. 11: 789-795. doi:10.1002/pds.1017.

Mather, Charles M. 2006. Medical innovation, unmet medical needs, and the
drug pipeline. The Canadian Journal of Clinical Pharmacology = Journal
Canadien De Pharmacologie Clinique 13, no. 1: e85-91.

Moore, Thomas J., Bruce M. Psaty, and Curt D. Furberg. 1998. Time to Act on
Drug Safety. JAMA 279, no. 19 (May 20): 1571-1573. doi:10.1001/jama.
279.19.1571.

Moynihan, Ray, Iona Heath, David Henry, and Peter C Gotzsche. 2002. Selling
sickness: the pharmaceutical industry and disease mongering * Commentary:
Medicalisation of risk factors. BMJ 324, no. 7342 (April 13): 886-891. doi:
10.1136/bmj.324.7342.886.

Muldoon, Chris. 2004. Pharmaceutical advertising: fact or fiction?

Pharmacoepidemiology and Drug Safety 13, no. 11: 801-802. doi:10.1002/pds.
1011.

Nelson R.C.[1], Palsulich B.[2], and Gogolak V.[3]. 2002. Good

Pharmacovigilance Practices: Technology Enabled. Drug Safety 25: 407-414.

O'Grady, Laura. 2006. Future directions for depicting credibility in health

care web sites. International Journal of Medical Informatics 75, no. 1
(January): 58-65. doi:10.1016/j.ijmedinf.2005.07.035.

O'Neill, Robert T., and Ana Szarfman. 2001. Some US Food and Drug
Administration perspectives on data mining for pediatric safety Assessment.
Current Therapeutic Research 62, no. 9 (September): 650-663. doi:10.1016/
S0011-393X(01)80071-0.

Orman, Levent V. 2002. Electronic Markets, Hierarchies, Hubs, and

Intermediaries. Information Systems Frontiers 4, no. 2 (July 1): 213-228.
doi:10.1023/A:1016007020846.

Pearson, Ronald K., Manfred Hauben, David I. Goldsmith, A. Lawrence Gould,

David Madigan, Donald J. O'Hara, Stephanie J. Reisinger, and Alan M.
Hochberg. 2009. Influence of the MedDRA® hierarchy on pharmacovigilance
data mining results. International Journal of Medical Informatics 78, no.
12 (December): e97-e103. doi:10.1016/j.ijmedinf.2009.01.001.

Power, Michael. 2005. The Invention of Operational Risk. Review of

International Political Economy 12, no. 4 (October): 577-599.

Rai, Arti K. 2001. The Information Revolution Reaches Pharmaceuticals:

Balancing Innovation Incentives, Cost, and Access in the Post-Genomics Era.
University of Illinois Law Review 2001 (January 1): 173-210.

Revicki, Dennis A, Robert M A Hirschfeld, Eileen P Ahearn, Richard H

Weisler, Cynthia Palmer, and Paul E Keck. 2005. Effectiveness and medical
costs of divalproex versus lithium in the treatment of bipolar disorder:
results of a naturalistic clinical trial. Journal of Affective Disorders
86, no. 2-3 (June): 183-193. doi:10.1016/j.jad.2005.01.002.
Rizzo, John A. 1999. Advertising and Competition in the Ethical
Pharmaceutical Industry: The Case of Antihypertensive Drugs. The Journal of
Law and Economics 42, no. 1: 89-116.

Rosoff, Arnold J. 1997. Changing Face of Pharmacy Benefits Management:

Information Technology Pursues a Grand Mission, The. Saint Louis University
Law Journal 42: 1.

Ruhleder, Karen, and John Leslie King. 1991. Computer support for work
across space, time, and social worlds. Journal of Organizational Computing
and Electronic Commerce 1, no. 4: 341. doi:10.1080/10919399109540168.

Sachs, G. S, C. F Baldassano, C. J Truman, and C. Guille. 2000. Comorbidity

of attention deficit hyperactivity disorder with early-and late-onset
bipolar disorder. American Journal of Psychiatry 157, no. 3: 466.

Sraffa, Piero. 1926. The Laws of Returns under Competitive Conditions. The
Economic Journal 36, no. 144 (December): 535-550.

Star, Susan Leigh, and James R. Griesemer. 1989. Institutional Ecology,

`Translations' and Boundary Objects: Amateurs and Professionals in
Berkeley's Museum of Vertebrate Zoology, 1907-39. Social Studies of Science
19, no. 3 (August 1): 387-420. doi:10.1177/030631289019003001.

Steinfield, Charles William. 2003. New directions in research on e-

commerce. Purdue University Press, December.

Woolgar, Steve. 1988. Time and documents in researcher interaction: Some

ways of making out what is happening in experimental science. Human Studies
11, no. 2 (April 1): 171-200. doi:10.1007/BF00177303.

Yates, JoAnne, and John Van Maanen. 2001. Information technology and
organizational transformation. SAGE.